Cita APA

Rodríguez García, E., Barrios Barrera, C., & Soler, M. J. (2017). Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?

Citación estilo Chicago

Rodríguez García, Eva, Clara Barrios Barrera, y María José Soler. Should Eculizumab Be Discontinued in Patients With Atypical Hemolytic Uremic Syndrome? 2017.

Cita MLA

Rodríguez García, Eva, Clara Barrios Barrera, y María José Soler. Should Eculizumab Be Discontinued in Patients With Atypical Hemolytic Uremic Syndrome? 2017.